Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac dosing for acute pain in ED
NCT03464461Phase 4Terminated
- Sponsor
- University of Missouri
- Start
- May 2018
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketorolac in acute pain, sponsored by University of Missouri. Started May 2018; status: terminated.
02
Drugs
ketorolac
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03464461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03464461.